Nebivolol: A Beta Blocker with A Twist - A Review of Its Distinctive Properties
Year: 2025
Type: article
Abstract: Nebivolol, a novel beta blocker, has emerged as a valuable treatment option for cardiovascular disease, offering a unique combination of beta-1 selectivity, vasodilatory effects, and antioxidant properties. This review article provides an in-depth examination of nebivolol's distinctive properties, exploring its pharmacological profile, clinical applications, and safety and tolerability. We discuss nebivolol's potential benefits for patients with hypertension, heart failure, and other cardiovascular conditions, highlighting its ability to improve cardiovascular outcomes, reduce blood pressure, and enhance quality of life. By elucidating the mechanisms underlying nebivolol's therapeutic effects, this review aims to provide a comprehensive understanding of its role in modern cardiovascular therapy, and to inform clinicians and researchers about the potential advantages of this innovative beta blocker.
Author: Sarika Pawar*, Dr. Jha Urmilesh, Dr. Avinash Mansukh, Chetana Padekar, Shraddha Shinde, Pratiksha Bhosale, Aniket Pawar
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6893307920
FWCI:
Cites:
Cited by:
Related to: